Results 71 to 80 of about 202,126 (199)

The ‘MAP strategy’ (Maximum aspiration of atherothrombus and adjunctive glycoprotein IIb/IIIa inhibitor utilization combined with prolonged inflation of balloon/stent) for preventing no-reflow in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: A retrospective analysis of seventy-one cases

Indian Heart Journal, 2015
‘No-reflow’ phenomenon is a common occurrence in percutaneous coronary intervention (PCI). A three-component ‘MAP strategy’ was designed to prevent no-reflow by addressing both intralesional and intraluminal thrombus in patients with ST-segment elevation
Anil Potdar, Satyavan Sharma
doaj   +1 more source

Multimodal Multiorgan‐on‐a‐Chip Platform for Probing Liver‐Tumor Interactions and Advancing Prodrug Screening

Advanced Science, Volume 13, Issue 34, 19 June 2026.
This work introduces a multimodal multi‐OoC platform that overcomes current limitations in liver‐tumor interaction studies and prodrug screening. By integrating dynamic microfluidic circuits, electrochemical sensing, and mass analysis, this platform enables non‐invasive, longitudinal monitoring of drug metabolism and hepatotoxicity, offering a ...
Dan Wang, Yisong Huang, Weijian Zhao, Tian Chen, Siyu Bai, Denghui Guo, Mengying Wang, Yaoyao Zhao, Liang Zhao, Guangsheng Guo, Xiayan Wang   +10 more
wiley   +1 more source

Myocardial no-reflow in humans

, 2009
In a variable proportion of patients presenting with ST-segment elevation myocardial infarction, ranging from 5% to 50%, primary percutaneous coronary intervention achieves epicardial coronary artery reperfusion but not myocardial reperfusion, a ...
Crea, Filippo, Burzotta, Francesco, Francesco Burzotta, Giampaolo Niccoli, Filippo Crea, Galiuto, Leonarda, Niccoli, Giampaolo, Leonarda Galiuto   +7 more
core   +2 more sources

Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion

Brazilian Journal of Medical and Biological Research, 2014
The mechanisms of statins relieving the no-reflow phenomenon and the effects of single-dose statins on it are not well known. This study sought to investigate the effects of inflammation on the no-reflow phenomenon in a rabbit model of acute myocardial ...
X.J. Zhao, X.L. Liu, G.X. He, H.P. Xu
doaj   +1 more source

CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous Coronary Intervention [PDF]

Journal of Cardiovascular and Thoracic Research, 2018
Introduction: No-reflow is one of the major complications of primary PCI in patients with acute ST elevation myocardial infarction. This phenomenon is associated with adverse outcomes in these patients.
Fardin Mirbolouk, Mahboobeh Gholipour, Arsalan Salari, Maryam Shakiba, Jalal kheyrkhah, Vahid Nikseresht, Nozar Sotoudeh, Negar Moghadam, Mohammad Jaafar Mirbolouk, Mani Moayeri far   +9 more
doaj   +1 more source

Clinical and Angiographic Predictors of No‐Reflow and Its Impact on Outcomes in ST‐Elevation Myocardial Infarction: A Retrospective Study

Clinical Cardiology, Volume 49, Issue 6, June 2026.
In 2925 STEMI patients undergoing primary PCI, no‐reflow occurred in 18% and was predicted by age, diabetes, Killip class, thrombus burden, TIMI 0 flow, and delayed presentation. No reflow was associated with higher mortality, complications, and MACE.
Husnain Bashir, F. N. U. Berkha, Jahanzeb Malik, Abida Perveen   +3 more
wiley   +1 more source

Redox Regulation and Oxidative Stress in Health and Disease: Mechanisms and Therapeutic Targeting

MedComm – Future Medicine, Volume 5, Issue 2, June 2026.
Reactive species serve crucial roles which are tightly regulated in both physiological as well as disease states. At physiological levels, these species are integral to redox signaling, while uncontrolled redox promotes disease pathology. This review examines the dysregulation of these processes.
Mohammad Hossein Azadi, Azadeh Niknejad, Elaheh Amini   +2 more
wiley   +1 more source

Management of No-Reflow Phenomenon in the Catheterization Laboratory

JACC: Cardiovascular Interventions, 2017
At the conclusion of a primary percutaneous coronary intervention for ST-segment elevation myocardial infarction, and after the cardiologist makes certain that there is no residual stenosis following stenting, assessment of coronary flow becomes the top priority. The presence of no-reflow is a serious prognostic sign.
Shereif H, Rezkalla, Rachel V, Stankowski, Jennifer, Hanna, Robert A, Kloner   +3 more
openaire   +2 more sources

Prevalence and Predictors of No-Reflow Phenomenon in Patients with Acute Coronary Syndrome in Slemani Cardiac Hospital

Advanced Medical Journal
Background and objectives: Understanding factors linked to the no-reflow phenomenon after percutaneous coronary intervention in acute coronary syndromes is important for optimizing reperfusion strategies.
Binar Yadgar Raouf Heshmet, Dana Hama Baqi Mohammed Saeed, Ammar Al-hamdi   +2 more
doaj   +1 more source

Crack Repair in Hydroxyapatite Bioceramics Using an Ultraviolet Ultrafast Laser

Advanced Materials Interfaces, Volume 13, Issue 10, 19 May 2026.
The study proposes an ultrafast ultraviolet laser approach to repair hidden tooth cracks, which has been preliminarily validated on HAP. Moreover, this technique aims to strengthen the native enamel structure rather than introducing a foreign filling material.
Yan Xue, Kai Zheng, Yang Liao, Jing Cao, Xupeng Yuan, Fusong Yuan, Yuxin Leng   +6 more
wiley   +1 more source